Werewolf Therapeutics (HOWL) Receivables - Other (2022 - 2024)
Werewolf Therapeutics (HOWL) has disclosed Receivables - Other for 3 consecutive years, with $464000.0 as the latest value for Q3 2024.
- On a quarterly basis, Receivables - Other fell 48.44% to $464000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $464000.0, a 48.44% decrease, with the full-year FY2023 number at $1.3 million, down 80.51% from a year prior.
- Receivables - Other was $464000.0 for Q3 2024 at Werewolf Therapeutics, down from $545000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $6.9 million in Q4 2022 to a low of $464000.0 in Q3 2024.
- A 3-year average of $2.4 million and a median of $1.6 million in 2023 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: skyrocketed 134.23% in 2023, then tumbled 89.52% in 2024.
- Werewolf Therapeutics' Receivables - Other stood at $6.9 million in 2022, then tumbled by 80.51% to $1.3 million in 2023, then tumbled by 65.63% to $464000.0 in 2024.
- Per Business Quant, the three most recent readings for HOWL's Receivables - Other are $464000.0 (Q3 2024), $545000.0 (Q2 2024), and $775000.0 (Q1 2024).